.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Express Scripts
Argus Health
Novartis
Federal Trade Commission
Chubb
McKesson
Farmers Insurance
Citi
Accenture

Generated: September 26, 2017

DrugPatentWatch Database Preview

Teva Parenteral Company Profile

« Back to Dashboard

What is the competitive landscape for TEVA PARENTERAL, and what generic and branded alternatives to TEVA PARENTERAL drugs are available?

TEVA PARENTERAL has forty-eight approved drugs.

There are six tentative approvals on TEVA PARENTERAL drugs.

Summary for Applicant: Teva Parenteral

Patents:0
Tradenames:40
Ingredients:38
NDAs:48
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Parenteral
AZITHROMYCIN
azithromycin
INJECTABLE;INJECTION050809-001Dec 19, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
SODIUM NITROPRUSSIDE
sodium nitroprusside
INJECTABLE;INJECTION073465-001Mar 30, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
METHYLPREDNISOLONE SODIUM SUCCINATE
methylprednisolone sodium succinate
INJECTABLE;INJECTION081268-001Nov 30, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
LEVALBUTEROL HYDROCHLORIDE
levalbuterol hydrochloride
SOLUTION;INHALATION200875-001Sep 11, 2014ANRXNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
GLYCOPYRROLATE
glycopyrrolate
INJECTABLE;INJECTION081169-001Sep 10, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
SUMATRIPTAN SUCCINATE
sumatriptan succinate
INJECTABLE;SUBCUTANEOUS078318-002Feb 6, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
METHYLPREDNISOLONE SODIUM SUCCINATE
methylprednisolone sodium succinate
INJECTABLE;INJECTION081266-001Nov 30, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
NEOSAR
cyclophosphamide
INJECTABLE;INJECTION040015-005Apr 29, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
LEUCOVORIN CALCIUM PRESERVATIVE FREE
leucovorin calcium
INJECTABLE;INJECTION040332-001Jun 28, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
ERYTHROMYCIN LACTOBIONATE
erythromycin lactobionate
INJECTABLE;INJECTION063253-002Jul 30, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Teva Parenteral

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Parenteral
CYTARABINE
cytarabine
INJECTABLE;INJECTION016793-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Teva Parenteral
CYTARABINE
cytarabine
INJECTABLE;INJECTION016793-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Novartis
Healthtrust
Baxter
Citi
Moodys
Chubb
Accenture
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot